Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy

Annals of the Rheumatic Diseases

Volumn 71, Issue 6, 2012, Pages 918-923

  Spinillo, Arsenio ^a   Beneventi, Fausta ^a   Ramoni, Véronique ^a   Caporali, Roberto ^a   Locatelli, Elena ^a   Simonetta, Margherita ^a   Cavagnoli, Chiara ^a   Alpini, Claudia ^a   Albonico, Giulia ^a   Prisco, Elena ^a   Montecucco, Carlomaurizio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; CORTICOSTEROID; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HOSPITAL ADMISSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; NEWBORN INTENSIVE CARE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESUSCITATION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CONNECTIVE TISSUE DISEASES; DIABETES, GESTATIONAL; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; HUMANS; MASS SCREENING; PILOT PROJECTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; PREVALENCE; QUESTIONNAIRES; RHEUMATIC DISEASES; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 84860918085     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-154146     Document Type: Article

References (40)

1. Mecacci F, Pieralli A, Bianchi B, et al. The impact of autoimmune disorders and adverse pregnancy outcome. Semin Perinatol 2007;31:223-6. (Pubitemid 47348100)
2. Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004;13:688-9. (Pubitemid 39279785)
3. Tincani A, Bompane D, Danieli E, et al. Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 2006;15:156-60.
4. Clowse ME. Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumatol 2010;24:373-85.
5. Ramoni V, Taraborelli M. Pregnancy and systemic sclerosis: data from a multicentric Italian study.(abstract). Ann Rheum Dis 2010;69(Suppl 3):419.
6. Spinillo A, Beneventi F, Epis OM, et al. The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome. Am J Obstet Gynecol 2008;199:632.e1-6.
7. Cavazzana I, Franceschini F, Belfiore N, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19:403-9. (Pubitemid 32685366)
8. Grava C, Ruffatti A, Milanesi O, et al. [Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sjögren's syndrome: a clinical study of 81 pregnancies in 41 patients]. Reumatismo 2005;57:180-6.
9. Spinillo A, Beneventi F, Epis OM, et al. Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two-steps strategy using a self-administered questionnaire and autoantibody testing. Br J Obstet Gynaecol 2008;115:51-7. (Pubitemid 350209610)
10. Bobbio-Pallavicini F, Alpini C, Caporali R, et al. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. Arthritis Res Ther 2004;6:R264-72.
11. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-8.
12. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21 (Suppl 2):B161-7. (Pubitemid 28357050)
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
14. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-65. (Pubitemid 34136572)
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
17. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
18. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
19. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
20. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
21. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989;16:328-34. (Pubitemid 19104571)
22. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999;17:615-20. (Pubitemid 29454836)
23. Frusca T, Soregaroli M, Valcamonico A, et al. Doppler velocimetry of the uterine arteries in nulliparous women. Early Hum Dev 1997;48:177-85. (Pubitemid 27153939)
24. Zhang WH, Alexander S, Bouvier-Colle MH, et al. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. Br J Obstet Gynaecol 2005;112:89-96. (Pubitemid 40095087)
25. Liang MH, Meenan RF, Cathcart ES, et al. A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum 1980;23:153-7. (Pubitemid 10164320)
26. Alarcón GS. Unclassified or undifferentiated connective tissue disease. Baillieres Best Pract Res Clin Rheumatol 2000;14:125-37. (Pubitemid 30353028)
27. Karlson EW, Sanchez-Guerrero J, Wright EA, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 1995;5:297-302.
28. Karlson EW, Costenbader KH, McAlindon TE, et al. High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women. Lupus 2005;14:832-6. (Pubitemid 41597619)
29. Benucci M, Del Rosso A, Li Gobbi F, et al. Systemic lupus erythematosus (SLE) in Italy: an Italian prevalence study based on a two-step strategy in an area of Florence (Scandicci-Le Signe). Med Sci Monit 2005;11:CR420-5. (Pubitemid 41330133)
30. Symmons DP. Looking back: rheumatoid arthritis-aetiology, occurrence and mortality. Rheumatology (Oxford) 2005;44 (Suppl 4):iv14-17. (Pubitemid 41724323)
31. Kabasakal Y, Kitapcioglu G, Turk T, et al. The prevalence of Sjögren's syndrome in adult women. Scand J Rheumatol 2006;35:379-83. (Pubitemid 44601072)
32. Doria A, Iaccarino L, Ghirardello A, et al. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Beçhet disease. Lupus 2004;13:690-5. (Pubitemid 39294715)
33. Mosca M, Tani C, Neri C, et al. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 2006;6:1-4. (Pubitemid 44724957)
34. Demaestri M, Sciascia S, Kuzenko A, et al. Neonatal lupus in triplet pregnancy of a patient with undifferentiated connective tissue disease evolving to systemic lupus erythematosus. Lupus 2009;18:368-71.
35. Marin GG, Cardiel MH, Cornejo H, et al. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 2009;15:325-9.
36. Petri M, Karlson EW, Cooper DS, et al. Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 1991;18:1529-31.
37. Shiel WC Jr, Jason M. The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol 1989;16:782-5. (Pubitemid 19182964)
38. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol 2004;150:751-5.
39. Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 2011;70:1083-6.
40. Brucato A, Cimaz R, Caporali R, et al. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2011;40:27-41.